Dec 22, 2025 04:01PM Amneal receives FDA approval for two denosumab biosimilar drugs

Dec 5, 2025 08:02AM Amneal reports positive interim results for Parkinson's drug CREXONT

Oct 30, 2025 06:04AM Amneal Pharmaceuticals (AMRX) Tops Q3 EPS by 3c, provides guidance

Oct 29, 2025 04:09PM Amneal receives tentative FDA approval for generic asthma inhaler

Sep 26, 2025 08:02AM Amneal submits biosimilar application for XOLAIR to FDA

Sep 22, 2025 03:15PM Amneal Pharmaceuticals (AMRX) 3500 contracts of October 10 calls trade

Aug 5, 2025 06:10AM Amneal Pharmaceuticals (AMRX) Tops Q2 EPS by 8c, raises guidance

Jul 21, 2025 07:40AM Amneal reports Q2 2025 preliminary results with revenue growth

Jun 25, 2025 08:04AM Amneal Pharmaceuticals (AMRX) Highlights Positive Topline Results from Confirmatory Clinical Study of Biosimilar Candidate to XOLAIR

Jun 12, 2025 08:01AM Amneal Pharmaceuticals (AMRX) Receives U.S. FDA Approval for Prednisolone Acetate Ophthalmic Suspension

Jun 6, 2025 03:30AM Goldman Sachs Starts Amneal Pharmaceuticals (AMRX) at Neutral

May 21, 2025 07:22AM Key Takeaways from Virtual Generics & Biosimilars Day at UBS

May 15, 2025 08:00AM Amneal Pharmaceuticals (AMRX) Receives U.S. FDA Approval for Brekiya

May 12, 2025 11:36AM Truist Lays Out Prelim Thoughts on Impact to Generic Drugs Amid WH Update on Drug Pricing

May 2, 2025 06:03AM Amneal Pharmaceuticals (AMRX) Tops Q1 EPS by 6c ; Offers Guidance

Apr 23, 2025 03:44PM Amneal Pharmaceuticals (AMRX) Recalls Ropivacaine Hydrochloride Injection

Apr 7, 2025 08:00AM Amneal Pharmaceuticals (AMRX) Announces New Data from Phase 3 Study Showing Significant Improvements in Sleep Quality with CREXONT

Apr 3, 2025 08:01AM Amneal Pharmaceuticals (AMRX) Announces Expanded Coverage for CREXONT to Enhance Access for Parkinson’s Disease Patients in the U.S.

Mar 3, 2025 04:10PM Amneal Pharmaceuticals' (AMRX) BLA Submissions for Two Denosumab Biosimilars Accepted for Review by U.S. FDA

Feb 28, 2025 06:06AM Amneal Pharmaceuticals (AMRX) Misses Q4 EPS by 3c ; Offers Guidance

Feb 24, 2025 01:04AM JPMorgan Upgrades Amneal Pharmaceuticals (AMRX) to Overweight

Feb 19, 2025 08:00AM Amneal Pharmaceuticals (AMRX) Launches Mesalamine and Receives U.S. FDA Approval for Lenalidomide

Jan 23, 2025 08:01AM Amneal Pharmaceuticals (AMRX) Receives U.S. FDA Approval for Memantine/Donepezil Extended-Release Capsules and Everolimus Tablets for Oral Suspension, and Tentative U.S. FDA Approval for Rifaximin

Nov 21, 2024 04:07PM Amneal Pharmaceuticals (AMRX) Resubmits DHE Autoinjector New Drug Application and Receives U.S. FDA Approval of Exenatide, its First Generic Injectable GLP-1 Agonist

Nov 11, 2024 07:22AM Amneal Pharmaceuticals (AMRX) PT Raised to $11 at Piper Sandler

Nov 8, 2024 06:02AM Amneal Pharmaceuticals (AMRX) Tops Q3 EPS by 3c, provides guidance

Oct 21, 2024 08:01AM Amneal Pharmaceuticals (AMRX) Receives U.S. FDA Approval of NDA for Pyridostigmine Bromide Extended-Release Tablets

Oct 2, 2024 06:37AM Amneal Pharmaceuticals (AMRX) PT Raised to $12 at Truist Securities

Oct 1, 2024 03:02PM Amneal Pharmaceuticals (AMRX) 4956 contracts of October 10 calls trade as share price up 5.2%

Oct 1, 2024 01:42PM Truist Securities Reiterates Buy Rating on Amneal Pharmaceuticals (AMRX)

Sep 23, 2024 08:13AM Amneal Pharmaceuticals (AMRX) Launches CREXONT Extended-Release Capsules for Treatment of Parkinson’s Disease

Sep 6, 2024 03:40AM JPMorgan Upgrades Amneal Pharmaceuticals (AMRX) to Neutral

Sep 5, 2024 04:06PM Amneal Pharmaceuticals (AMRX) and Shilpa Announce U.S. FDA Approval of BORUZU

Aug 20, 2024 08:01AM Amneal Pharmaceuticals (AMRX) Receives U.S. FDA Approval for Propofol Injectable Emulsion Single Dose Vials

Aug 9, 2024 06:07AM Amneal Pharmaceuticals (AMRX) Tops Q2 EPS by 2c, provides guidance

Jul 29, 2024 04:05PM Amneal Pharmaceuticals (AMRX) Receives U.S. FDA Approval for Potassium Phosphates Injection IV Bags

Jul 9, 2024 04:05PM Amneal Pharmaceuticals (AMRX) Launches FOCINVEZ